It’s late but it’s better than_老虎社区_美港股上老虎

2021-06-10

It’s late but it’s better than never

Pfizer to provide U.S. with 500 million COVID-19 vaccines to donate to world

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":183311163,"tweetId":"183311163","gmtCreate":1623306738152,"gmtModify":1634034733079,"author":{"id":3574567062675330,"idStr":"3574567062675330","authorId":3574567062675330,"authorIdStr":"3574567062675330","name":"Clc2","avatar":"https://static.tigerbbs.com/80838f8bfa83dda6b2b71ab122d80561","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>It’s late but it’s better than never</p></body></html>","htmlText":"<html><head></head><body><p>It’s late but it’s better than never</p></body></html>","text":"It’s late but it’s better than never","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/183311163","repostId":2142024176,"repostType":4,"repost":{"id":"2142024176","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623305400,"share":"https://www.laohu8.com/m/news/2142024176?lang=&edition=full","pubTime":"2021-06-10 14:10","market":"us","language":"en","title":"Pfizer to provide U.S. with 500 million COVID-19 vaccines to donate to world","url":"https://stock-news.laohu8.com/highlight/detail?id=2142024176","media":"Reuters","summary":"BERLIN, June 10 (Reuters) - Pfizer and German partner BioNTech said on Thursday they have agreed to ","content":"<p>BERLIN, June 10 (Reuters) - Pfizer and German partner BioNTech said on Thursday they have agreed to supply the U.S. government with 500 million doses of their COVID-19 vaccine to donate to poorer countries over the next two years.</p>\n<p>The two drugmakers will provide 200 million doses in 2021 and 300 million doses in the first half of 2022, which the United States will then distribute to 92 lower-income countries and the African Union, they said.</p>\n<p>The shots, which will be produced at Pfizer's U.S. production sites, will be provided at a not-for-profit price.</p>\n<p>\"Our partnership with the U.S. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible,\" said Pfizer Chief Executive Albert Bourla.</p>\n<p>Deliveries of the 200 million doses will begin in August 2021 and continue through the remainder of the year, they said, while the 300 million doses for 2022 are planned to be delivered between January and the end of June.</p>\n<p>The U.S. government also has the option for additional doses.</p>\n<p>Pfizer and Biontech said the doses are part of a previously announced pledge to provide two billion doses of the COVID-19 vaccine to low- and middle-income countries over the next 18 months.</p>\n<p>Reuters reported on Wednesday the Biden Administration plans to donate coronavirus vaccines to lower-income countries.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer to provide U.S. with 500 million COVID-19 vaccines to donate to world</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer to provide U.S. with 500 million COVID-19 vaccines to donate to world\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-10 14:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BERLIN, June 10 (Reuters) - Pfizer and German partner BioNTech said on Thursday they have agreed to supply the U.S. government with 500 million doses of their COVID-19 vaccine to donate to poorer countries over the next two years.</p>\n<p>The two drugmakers will provide 200 million doses in 2021 and 300 million doses in the first half of 2022, which the United States will then distribute to 92 lower-income countries and the African Union, they said.</p>\n<p>The shots, which will be produced at Pfizer's U.S. production sites, will be provided at a not-for-profit price.</p>\n<p>\"Our partnership with the U.S. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible,\" said Pfizer Chief Executive Albert Bourla.</p>\n<p>Deliveries of the 200 million doses will begin in August 2021 and continue through the remainder of the year, they said, while the 300 million doses for 2022 are planned to be delivered between January and the end of June.</p>\n<p>The U.S. government also has the option for additional doses.</p>\n<p>Pfizer and Biontech said the doses are part of a previously announced pledge to provide two billion doses of the COVID-19 vaccine to low- and middle-income countries over the next 18 months.</p>\n<p>Reuters reported on Wednesday the Biden Administration plans to donate coronavirus vaccines to lower-income countries.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142024176","content_text":"BERLIN, June 10 (Reuters) - Pfizer and German partner BioNTech said on Thursday they have agreed to supply the U.S. government with 500 million doses of their COVID-19 vaccine to donate to poorer countries over the next two years.\nThe two drugmakers will provide 200 million doses in 2021 and 300 million doses in the first half of 2022, which the United States will then distribute to 92 lower-income countries and the African Union, they said.\nThe shots, which will be produced at Pfizer's U.S. production sites, will be provided at a not-for-profit price.\n\"Our partnership with the U.S. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible,\" said Pfizer Chief Executive Albert Bourla.\nDeliveries of the 200 million doses will begin in August 2021 and continue through the remainder of the year, they said, while the 300 million doses for 2022 are planned to be delivered between January and the end of June.\nThe U.S. government also has the option for additional doses.\nPfizer and Biontech said the doses are part of a previously announced pledge to provide two billion doses of the COVID-19 vaccine to low- and middle-income countries over the next 18 months.\nReuters reported on Wednesday the Biden Administration plans to donate coronavirus vaccines to lower-income countries.","news_type":1},"isVote":1,"tweetType":1,"viewCount":376,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":30,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/183311163"}